Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group

Goey, K.K.H.; Sørbye, H.; Glimelius, B.; Adams, R.A.; André, T.; Arnold, D.; Berlin, J.D.; Bodoky, G.; de Gramont, A.; Díaz-Rubio, E.; Eng, C.; Falcone, A.; Grothey, A.; Heinemann, V.; Hochster, H.S.; Kaplan, R.S.; Kopetz, S.; Labianca, R.; Lieu, C.H.; Meropol, N.J.; et al.

doi:10.1016/j.ejca.2018.05.010

Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group

Date

2018

Authors

Goey, K.K.H.

Sørbye, H.

Glimelius, B.

Adams, R.A.

André, T.

Arnold, D.

Berlin, J.D.

Bodoky, G.

de Gramont, A.

Díaz-Rubio, E.

Type:

Journal article

Citation

European Journal of Cancer, 2018; 100:35-45

Statement of Responsibility

Kaitlyn K.H. Goey ... Timothy J. Price ... et al.

DOI

10.1016/j.ejca.2018.05.010

Abstract

Abstract not available

Description

Available online 22 June 2018

Rights

Published Version

https://doi.org/10.1016/j.ejca.2018.05.010

Persistent link to this record

http://hdl.handle.net/2440/115003

Full item page

Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group

Date

Authors

Editors

Advisors

Journal Title

Journal ISSN

Volume Title

Type:

Citation

Statement of Responsibility

Conference Name

DOI

Abstract

School/Discipline

Dissertation Note

Provenance

Description

Access Status

Rights

License

Grant ID

Published Version

Call number

Persistent link to this record